BibTex RIS Kaynak Göster

Kas Gevşetici İlaç Cabral®(Feniramidol)’ın Mutajenik Etkisinin Ames Salmonella/Mikrozom Test Yöntemi İle Araştırılması

Yıl 2016, , 67 - 73, 31.07.2016
https://doi.org/10.17714/gufbed.2016.06.008

Öz

Günümüzde yaygın olarak kullanılan feniramidol (Cabral®) kas gevşetici etki gösteren analjezik bir ilaçtır. Bu çalışmada amaç feniramidol’ün potansiyel mutajenik etkisinin Ames Salmonella/Mikrozom test sistemi ile saptanmasıdır. Bu amaçla mutajenik etkiyi belirlemek için feniramidol’ün ticari formu olan Cabral®’ın 5 farklı dozu (0.1-1000 µg/plak) Salmonella typhimurium’un TA98 ve TA100 suşları ile muamele edilmiştir. Elde edilen bulgulara göre feniramidol’ün denenen hiçbir dozu TA98 ve TA100 suşlarında mutajenik etki göstermemiştir.

Kaynakça

  • Balbi, A., Muscettola, G., Staiano, N., Martire, G. ve De Lorenzo, F., 1980. Psychotropic drugs: evaluation of mutagenic effect, Pharmacological Research Communications, 12, 423-431.
  • Black, H., Szot, R., Arthaud, L., Massa, T., Mylecraine, L., Klein, M., et al., 1987. Preclinical safety evaluation of the benzodiazepine quazepam, Arzneimittel-Forschung/Drug Research, 37, 8 906-913.
  • Boyacıoğlu, M., Arslan, Ç.Ö., Parlak, H. ve Karaaslan, M., 2007. Mutagenicity of Nonylphenol and Octylphenol Using Salmonella Mutation Assay, E.U. Journal of Fisheries & Aquatic Sciences, 24, 3-4, 299–302.
  • Bökesoy, T. A., Çakıcı, İ. ve Melli, M., 2000, Genel Farmakoloji ve Toksikoloji, Gazi Kitabevi, Ankara, 86-101s.
  • Brambillaa, G., Carrozzinob, R. ve Martellia, A., 2007. Genotoxicity and carcinogenicity studies of benzodiazepines, Pharmacological Research, 56, 6, 443-458.
  • Chlopkiewicz, B., Ejchart, A. ve Anuszewska, E., 2001. Tofisopam—evaluation of mutagenic and genotoxic properties, Acta Poloniae Pharmaceutica - Drug Research, 58, 31-34.
  • Dean, B., Brooks, T., Hodson-Walker, G. ve Hutson, D., 1985. Genetic toxicology testing of 41 Industrial chemicals, Mutation Research, 153, 57-77.
  • Debnath, A., Compadre, R., Debnath, G., Shusterman, A. ve Hansch, G., 1991. Strure-Activity Relationship of Mutagenic Aromatic and Heteroaromatic Nitro Compounds Correletion Molecular with Orbital Energies and Hydrophobicity, Journal of Medicinal Chemistry, 34, 2, 786-797.
  • Ibrulj, S. ve Nefıc, H., 1999. Diazepem induced chromosome aberrations in human lymphocytes in vitro, Medicinski arhiv, 53, 1, 3-5.
  • Igloe, M.C., 1963. The use of injectable phenyramidol in musculoskeletal disorders, Industrial Medicine & Surgery, 32, 242-247.
  • Karahalil, B., Yağar, S., Bahadır, G., Durak, P. ve Sardaş, S., 2005. Diazepam and propofol used as anesthetics during open-heart surgery do not cause chromosomal aberrations in peripheral blood lymphocytes, Mutation Research, 581, 1-2, 181-186.
  • Kayraldız, A.,, Kaya, F. F., Canımoglu, S. ve Rencüzoğulları, E., 2006. Mutagenicity of five food additives in Ames/Salmonella/Microsome test, Annals of Microbiology, 56, 2, 129-133.
  • Kier, L., Brusick, D., Auletta, A., Halle, E.V., Brown, M., Simmon, V., et al., 1986. The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program, Mutation Research, 168, 2, 69-240.
  • Köksal, A., Köklü, S., Filik, L., Şaşmaz, N. ve Şahin, B., 2003. Phenyramidol– Associated Liver Toxicity, Annals of Pharmacotherapy, 37, 1244-1246.
  • Koksal, P.M. ve Gürbüzel, M., 2015. Analysis of genotoxic activity of ketamine and rocuronium bromide using the somatic mutation and recombination test in Drosophila melanogaster, Environmental Toxicology and Pharmacology, 39(2): 628-634.
  • Kutlu, M., Öztaş, E., Aydoğan, G., Işıkdağ, İ. ve Özkay, Y., 2011. Bazı 9-Sübstitüe Fenantren Türevlerinin Mutajenik Aktivitelerinin Ames/Salmonella/ Mikrozom Testi İle Araştırılması, Anadolu Üniversitesi Bilim ve Teknoloji Dergisi-Yaşam Bilimleri ve Biyoteknoloji, 1,1, 83-94.
  • Leal, C.G., Valencıan, G., Rojas, M. ve Cortes, E.G., 1998. Mutagenic activity of diazepam evaluated by in vivo cytogenetic tests, Archives of Medical Research, 29, 4, 285-289.
  • Maron, D. ve Ames, B., 1983. Revised methods for the Salmonella mutagenicity test, Mutation Research, 113, 173-215.
  • Mortelmans K. ve Zeiger, E.E., 2000. The Ames Salmonella/microsome mutagenicity assay, Mutation Research, 455, 1-2, 29-60.
  • O’Dell, T., Wilson, L., Napoli, M., White, H. ve Mirsky, J.H., 1960. Pharmacology of a series of new 2-substituted pyridine derivatives with emphasis on their analgesic and interneuronal blocking properties, The Journal of Pharmacology and Experimental Therapeutics, 28, 65-74.
  • Staiano, M. N., Belisario, R., Morte, C.D., Farina, P. ve Rimondelli, G., 1984. Muscettola Mutagenic effects of flunitrazepam, Bollettino della Societa Italiana di Biologia Sperimentale, 60, 2247-2253.
  • Stoyanov, I., Nikolov, I., Chernozemskii, I. ve Stoichev, I., 1987. Assessment for mutagenicity of 10 pharmaceutical products following Ames, micronucleus, and sperm morphology testing, Toxicity Assessment, 2, 2, 207-215.
  • Synder, L. ve Champness, W., 2007. Third Edition Moleküler Genetics of Bacteria, Department of Microbiology and Moleculer Genetics, Michigon State University East Lansing, Michigan Washigton, DC, 492.
  • Veronese, M. ve Barzaghi, D., 1987. Experimental studies in vitro and in vivo on the mutagenicity of flavoxate, Arzneimittel-Forschung, 37, 5, 528-531.
  • Wakisaka, Y. ve Nishimoto, Y., 1987. Mutagenicity study on a new sleep inducer, a 1H-1,2,4-triazolylbenzophenone derivative (450191-S), and its metabolite in bacteria. Iyakuhin Kenkyu, 18, 12-20.
Toplam 25 adet kaynakça vardır.

Ayrıntılar

Bölüm Makaleler
Yazarlar

Mehmet Arslan

Yayımlanma Tarihi 31 Temmuz 2016
Gönderilme Tarihi 17 Ocak 2016
Yayımlandığı Sayı Yıl 2016

Kaynak Göster

APA Arslan, M. (2016). Kas Gevşetici İlaç Cabral®(Feniramidol)’ın Mutajenik Etkisinin Ames Salmonella/Mikrozom Test Yöntemi İle Araştırılması. Gümüşhane Üniversitesi Fen Bilimleri Dergisi, 6(2), 67-73. https://doi.org/10.17714/gufbed.2016.06.008